Drexel Morgan & Co’s Clorox CLX Stock Holding History

Drexel Morgan & Co’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,415	Closed	-$273K	–	84
2021 Q1	$273K	Hold	1,415	–	–	0.07%	92
2020 Q4	$286K	Hold	1,415	–	–	0.08%	89
2020 Q3	$297K	Buy	+1,415	New	+$315K	0.1%	78

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Drexel Morgan & Co's CLX Position: Q2 2021 in Review

Drexel Morgan & Co sold out of Clorox (CLX) in Q2 2021, closing a stake of 1,415 shares — an estimated $273K sold.

Drexel Morgan & Co first reported a position in CLX in Q3 2020 and held it in 3 quarters. The position peaked at $297K in Q3 2020. 1,168 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

Drexel Morgan & Co reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
Drexel Morgan & Co sold 1,415 Clorox shares in Q2 2021, an estimated $273K.
Drexel Morgan & Co first reported a position in Clorox in Q3 2020 and held it in 3 quarters.
Drexel Morgan & Co's Clorox position peaked at $297K in Q3 2020.
1,168 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Drexel Morgan & Co's 13F filing for Q2 2021, filed 12 Aug 2021.